Comparison of central venous minus arterial carbon dioxide pressure to arterial minus central venous oxygen content ratio and lactate levels as predictors of mortality in critically ill patients: a systematic review and meta-analysis

A. Dubin, C. Loudet, F. J. Hurtado, M. Pozo, D. Comandé, Luz Gibbons, F. Cairoli, Ariel Esteban Bardach
{"title":"Comparison of central venous minus arterial carbon dioxide pressure to arterial minus central venous oxygen content ratio and lactate levels as predictors of mortality in critically ill patients: a systematic review and meta-analysis","authors":"A. Dubin, C. Loudet, F. J. Hurtado, M. Pozo, D. Comandé, Luz Gibbons, F. Cairoli, Ariel Esteban Bardach","doi":"10.5935/0103-507X.20220026-en","DOIUrl":null,"url":null,"abstract":"Objective The central venousarterial carbon dioxide pressure to arterial-central venous oxygen content ratio (Pcv-aCO2/Ca-cvO2) is frequently used as a surrogate for tissue oxygenation. We aimed to identify and synthesize literature and quality of evidence supporting Pcv-aCO2/Ca-cvO2 as a predictor of mortality in critically ill patients compared with lactate. Methods We searched several databases for studies measuring Pcv-aCO2/Ca-cvO2 in critically ill patients. Independent investigators performed the article screening and data extraction. A random-effects metaanalysis was performed. Pooled standardized mean differences (SMD) were used to compare the prognostic ability of Pcv-aCO2/Ca-cvO2 and lactate. Results We initially retrieved 172 studies; 17 were included for qualitative description, and 10 were included for quantitative synthesis. The mean Pcv-aCO2/Ca-cvO2 was higher in nonsurvivors than in survivors (pooled SMD = 0.75; 95%CI 0.34 - 1.17; I2 = 83%), as was the case with lactate levels (pooled SMD = 0.94; 95%CI 0.34 - 1.54; I2 = 92%). Both tests were statistically significant predictors of mortality, albeit with overlapping 95%CIs between them. Conclusion Moderate-quality evidence showed little or no difference in the ability of Pcv-aCO2/Ca-cvO2, compared with lactate, to predict mortality. Nevertheless, our conclusions are limited by the considerable heterogeneity among the studies. PROSPERO registration: CRD42019130387","PeriodicalId":53519,"journal":{"name":"Revista Brasileira de Terapia Intensiva","volume":"34 1","pages":"279 - 286"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira de Terapia Intensiva","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/0103-507X.20220026-en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objective The central venousarterial carbon dioxide pressure to arterial-central venous oxygen content ratio (Pcv-aCO2/Ca-cvO2) is frequently used as a surrogate for tissue oxygenation. We aimed to identify and synthesize literature and quality of evidence supporting Pcv-aCO2/Ca-cvO2 as a predictor of mortality in critically ill patients compared with lactate. Methods We searched several databases for studies measuring Pcv-aCO2/Ca-cvO2 in critically ill patients. Independent investigators performed the article screening and data extraction. A random-effects metaanalysis was performed. Pooled standardized mean differences (SMD) were used to compare the prognostic ability of Pcv-aCO2/Ca-cvO2 and lactate. Results We initially retrieved 172 studies; 17 were included for qualitative description, and 10 were included for quantitative synthesis. The mean Pcv-aCO2/Ca-cvO2 was higher in nonsurvivors than in survivors (pooled SMD = 0.75; 95%CI 0.34 - 1.17; I2 = 83%), as was the case with lactate levels (pooled SMD = 0.94; 95%CI 0.34 - 1.54; I2 = 92%). Both tests were statistically significant predictors of mortality, albeit with overlapping 95%CIs between them. Conclusion Moderate-quality evidence showed little or no difference in the ability of Pcv-aCO2/Ca-cvO2, compared with lactate, to predict mortality. Nevertheless, our conclusions are limited by the considerable heterogeneity among the studies. PROSPERO registration: CRD42019130387
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中心静脉负动脉二氧化碳压与动脉负中心静脉氧含量比和乳酸水平作为危重患者死亡率预测因子的比较:系统回顾和荟萃分析
目的中心静脉动脉二氧化碳压与动脉-中心静脉氧含量比(Pcv-aCO2/Ca-cvO2)常被用作组织氧合的替代指标。我们的目的是鉴别和综合支持Pcv-aCO2/Ca-cvO2与乳酸相比可作为危重患者死亡率预测因子的文献和证据质量。方法检索多个数据库,查找危重患者Pcv-aCO2/Ca-cvO2的相关研究。独立调查人员进行了文章筛选和数据提取。进行随机效应荟萃分析。采用合并标准化平均差异(SMD)比较Pcv-aCO2/Ca-cvO2和乳酸的预后能力。我们最初检索了172项研究;其中17个用于定性描述,10个用于定量综合。非幸存者的平均Pcv-aCO2/Ca-cvO2高于幸存者(合并SMD = 0.75;95%ci 0.34 - 1.17;I2 = 83%),乳酸水平也是如此(汇总SMD = 0.94;95%ci 0.34 - 1.54;I2 = 92%)。尽管两者之间95% ci重叠,但这两项测试在统计上都是死亡率的显著预测指标。结论中等质量的证据显示,与乳酸相比,Pcv-aCO2/Ca-cvO2预测死亡率的能力几乎没有差异。然而,我们的结论受到研究之间相当大的异质性的限制。普洛斯彼罗注册号:CRD42019130387
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Revista Brasileira de Terapia Intensiva
Revista Brasileira de Terapia Intensiva Medicine-Critical Care and Intensive Care Medicine
自引率
0.00%
发文量
114
审稿时长
15 weeks
期刊最新文献
Patient-level costs of central line-associated bloodstream infections caused by multidrug-resistant microorganisms in a public intensive care unit in Brazil: a retrospective cohort study Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens. Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults. Robust, maintainable, emergency invasive mechanical ventilator. Erratum.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1